Registry Maastro Applicator
Recruiting now
Conditions studied: Rectal Cancer
In brief
This registry will collect data from all patients treated with the MAASTRO HDR applicator. The goal is to deepen knowledge about dose-response relationships in rectal cancer boosting, which is essential for improving future treatment approaches and patient selection.
Key facts
- Study ID
- NCT07501845
- Run by
- Maastricht Radiation Oncology
- People needed
- 999
- Starts
- 2026-03-23
- Expected to finish
- 2034-12-31
- Last updated by the study team
- 2026-04-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 18 years.
- Histological proof of rectal cancer, or a strong suspicion after imaging.
- Treatment with MAASTRO HDR rectal applicator
- Informed consent for longitudinal observational data collection.
You may not qualify if…
- Mentally incompetent patients.
Where it is running
- Maastro — Maastricht, Netherlands (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.